These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 37013511)
1. Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis. Tang W; Shao Q; He Z; Zhang X; Li X; Wu R BMC Cancer; 2023 Apr; 23(1):303. PubMed ID: 37013511 [TBL] [Abstract][Full Text] [Related]
2. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker. Zhang D; Liang P; Xia B; Wu J; Hu X BMC Cancer; 2024 Aug; 24(1):987. PubMed ID: 39123194 [TBL] [Abstract][Full Text] [Related]
4. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective. Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y Front Immunol; 2022; 13():1062225. PubMed ID: 36605187 [TBL] [Abstract][Full Text] [Related]
5. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma. Chen CC; Chu PY; Lin HY Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154 [TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
7. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening. Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208 [TBL] [Abstract][Full Text] [Related]
8. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates. Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma. Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint. Bai KH; Zhang YY; Li XP; Tian XP; Pan MM; Wang DW; Dai YJ Comput Struct Biotechnol J; 2022; 20():5226-5234. PubMed ID: 36187930 [TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (BAP1): Friend or foe? Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q Gene; 2022 Oct; 840():146765. PubMed ID: 35905855 [TBL] [Abstract][Full Text] [Related]
12. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma. Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541 [TBL] [Abstract][Full Text] [Related]
13. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma. Zou X; Mo Z Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value and immunological role of cathepsin S gene in pan‑cancer. Liang S; Dang B; Chen S; Mi H Oncol Lett; 2024 Jan; 27(1):41. PubMed ID: 38108072 [TBL] [Abstract][Full Text] [Related]
15. An Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292 [TBL] [Abstract][Full Text] [Related]
16. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma. Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y Front Genet; 2023; 14():1109991. PubMed ID: 36992705 [No Abstract] [Full Text] [Related]
17. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization. Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y Front Immunol; 2023; 14():1224904. PubMed ID: 37809090 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive analysis of essential meiotic endonuclease 1 to prognosis and immune infiltration in kidney renal clear cell carcinoma. Li HD; Ma HX; Ma JH; Kong SP; Zhao ST; Fan SQ; Qin F; Ma JG Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):584-602. PubMed ID: 38305603 [TBL] [Abstract][Full Text] [Related]
19. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma. Cheng L; Mi J; Zhang J; Huang H; Mo Z Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660 [TBL] [Abstract][Full Text] [Related]
20. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]